Literature DB >> 32512082

Handheld ultrasound devices: An emerging technology to reduce viral spread during the Covid-19 pandemic.

Lauren E Gibson1, Edward A Bittner1, Marvin G Chang2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32512082      PMCID: PMC7273157          DOI: 10.1016/j.ajic.2020.05.041

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


× No keyword cloud information.
Coronavirus 2019 (COVID-19) is highly contagious and has spread around the world at an unprecedented rate. The American College of Radiology has discouraged the use of routine imaging studies to reduce risk of contamination. Ultrasound is useful for ventilatory and hemodynamics optimization, and has been shown to be superior to the stethoscope and chest radiography, and comparable to computed tomography in the diagnosis of many pathologies. Handheld ultrasound devices fit into a single-use plastic cover (Fig 1 ) and can be easily decontaminated, making them ideal for minimizing viral contamination and sperad during the COVID-19 pandemic.
Fig. 1

A portable ultrasound device and connected tablet can be placed in a single-use plastic sheath prior to entering a patient's room to minimize the risk of viral contamination and spread.

A portable ultrasound device and connected tablet can be placed in a single-use plastic sheath prior to entering a patient's room to minimize the risk of viral contamination and spread. Table 1 shows the duration that many common hospital pathogens are viable on surfaces. While many pathogens are viable for much longer than SARS-CoV-2, their level of contagiousness is markedly diminished. A survey by Westerway et al found that a majority of ultrasound users did not appropriately disinfect traditional ultrasound machines, with only 47% using proper disinfectant solution and only 15% and 47% disinfecting the keyboard and cords, respectively. Single use gels should also be used given that community gel has been a source of contamination. As many in-hospital providers are burdened with increasing patient volumes during the current pandemic, there could be even less adherence to best practices for decontamination.
Table 1

Survival time of common hospital pathogens on dry inaminate surfaces.

Type of pathogenDuration of persistence
Bacteria
Acinetobacter spp.3 days to 5 months
Clostiridium difficile5 months
Escherichia coli1.5 hours to 16 months
Enterococcus spp.5 days to 4 months
Haemophilus influenza12 days
Klebsiella spp.2 hours to >30 months
Listeria spp.1 day to months
Mycobacterium tuberculosisUp to 4 months
Proteus vulgarisUp to 2 days
Pseudomonas aeruginosaUp to 16 months
Serratia marcescens3 days to 2 months
Staphylococcus aureusUp to 7 months
Streptococcus pneumoniae1 to 20 days
Streptococcus pyogenes3 days to 6.5 months
Fungi
Candida albicansUp to 120 days
Torulopsis glabrata102 to 150 days
Viruses
Adenovirus7 days to 3 months
HAV2 hours to 60 days
HBVGreater than one week
HIVGreater than 7 days
HSV4.5 hours to 8 weeks
Influenza virus1 to 2 days
Norovirus8 hours to 7 days
MERS-CoVUp to 48 hours
Respiratory syncytial virusUp to 6 hours
SARS-CoV3 to 10 days
SARS-CoV-2Up to 3 days

Adapted from Kramer et al, Otter et al, and van Doremalen et al.

Survival time of common hospital pathogens on dry inaminate surfaces. Adapted from Kramer et al, Otter et al, and van Doremalen et al. Because of their compact size and profile, handheld devices can be easily decontaminated with a single disinfectant wipe. In contast, decontamination of traditional ultrasound machines can be challenging if not impossible due to greater surface area, and components such as keyboards, knobs, and cords. This process can be time consuming and costly, as many hospitals are rationing disinfectant supplies. In addition, many handheld ultrasound devices now have teleguidance capabilities that allow experts to guide a novice user through an exam remotely thereby minimizing exposure, conserving personal protective equipment, and reducing patient transport for imaging studies. Nurses and respiratory therapists can also be easily trained to perform focused ultrasound assessments. , During the current pandemic, disease containment and provider safety are high priorities. We must embrace emerging technologies such as handheld ultrasound devices to allow us to achieve these aims while providing high quality care to our patients.
  8 in total

1.  A Surge of FoCUS on COVID-19 POCUS.

Authors:  Lauren E Gibson; David Convissar; Lorenzo Berra; Edward A Bittner; Marvin G Chang
Journal:  Anesth Analg       Date:  2020-07-21       Impact factor: 5.108

2.  Ultrasound-guided peripheral intravenous cannulation for patients requiring dental surgery under intravenous dental sedation.

Authors:  Ishfaq Khan
Journal:  Br Dent J       Date:  2022-04-08       Impact factor: 2.727

Review 3.  The Use of Handheld Ultrasound Devices in Emergency Medicine.

Authors:  Adrienne N Malik; Jonathan Rowland; Brian D Haber; Stephanie Thom; Bradley Jackson; Bryce Volk; Robert R Ehrman
Journal:  Curr Emerg Hosp Med Rep       Date:  2021-05-11

4.  Biplane Imaging Using Portable Ultrasound Devices for Vascular Access.

Authors:  David Convissar; Edward A Bittner; Marvin G Chang
Journal:  Cureus       Date:  2021-01-07

5.  The Utility of Handheld Cardiac and Lung Ultrasound in Predicting Outcomes of Hospitalised Patients With COVID-19.

Authors:  Ziv Dadon; Nir Levi; Amir Orlev; Daniel Belman; Evan Avraham Alpert; Michael Glikson; Shmuel Gottlieb; Adi Butnaru
Journal:  Can J Cardiol       Date:  2021-12-03       Impact factor: 5.223

6.  The quality, safety, feasibility, and interpretive accuracy of echocardiographic and lung ultrasound assessment of COVID-19 patients using a hand-held ultrasound.

Authors:  Ziv Dadon; Nir Levi; Evan Avraham Alpert; Amir Orlev; Daniel Belman; Michael Glikson; Adi Butnaru; Shmuel Gottlieb
Journal:  Echocardiography       Date:  2022-06-06       Impact factor: 1.874

7.  Use of Handheld Ultrasound Device with Artificial Intelligence for Evaluation of Cardiorespiratory System in COVID-19.

Authors:  Harish M Maheshwarappa; Shivangi Mishra; Anuja V Kulkarni; Vikneswaran Gunaseelan; Muralidhar Kanchi
Journal:  Indian J Crit Care Med       Date:  2021-05

8.  In Response.

Authors:  Lauren E Gibson; David Convissar; Lorenzo Berra; Edward A Bittner; Marvin G Chang
Journal:  Anesth Analg       Date:  2020-11       Impact factor: 6.627

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.